Insulin receptor-independent upregulation of cellular glucose uptake

International Journal of Obesity

Volumn 37, Issue 1, 2013, Pages 146-153

  Krishnapuram, R ^a   Kirk Ballard, H ^a   Dhurandhar, E J ^a   Dubuisson, O ^a   Messier, V ^b,c   Rabasa Lhoret, R ^b,c   Hegde, V ^a   Aggarwal, S ^a   Dhurandhar, N V ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Ad36; Glut 4; IRS1; p53; PI3K; Ras

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN RECEPTOR; PROTEIN P53; RAS PROTEIN; SMALL INTERFERING RNA;

ADENOVIRUS; ADENOVIRUS INFECTION; ADIPOCYTE; ANIMAL TISSUE; ARTICLE; CELL TRANSFORMATION; CONTROLLED STUDY; FEMALE; GENE SILENCING; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; INSULIN RESISTANCE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

3T3-L1 CELLS; ADENOVIRUS INFECTIONS, HUMAN; ADENOVIRUSES, HUMAN; ANIMALS; BLOTTING, WESTERN; CELL CULTURE TECHNIQUES; FEMALE; GENES, P53; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; HUMANS; MALE; MICE; MICE, INBRED C57BL; RAS PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION; UP-REGULATION;

HUMAN ADENOVIRUS; MUS;

EID: 84872118400     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2012.6     Document Type: Article

References (51)

1. Jiang ZY, Zhou QL, Coleman KA, Chouinard M, Boese Q, Czech MP. Insulin signaling through Akt/protein kinase B analyzed by small interfering RNA-mediated gene silencing. Proc Natl Acad Sci USA 2003; 100: 7569-7574.
2. Goodyear LJ, Giorgino F, Sherman LA, Carey J, Smith RJ, Dohm GL. Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidy-linositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. J Clin Invest 1995; 95: 2195-2204.
3. Pessin JE, Saltiel AR. Signaling pathways in insulin action: molecular targets of insulin resistance.J Clin Invest2000; 106: 165-169.
4. Sesti G, Federici M, Hribal ML, Lauro D, Sbraccia P, Lauro R. Defects of the insulin receptor substrate (IRS) system in human metabolic disorders. FASEBJ 2001; 15: 2099-2111.
5. Klip A. The many ways to regulate glucose transporter 4. Appl Physiol Nutr Metab 2009; 34: 481 -487.
6. Tanaka T, Nakatani K, Morioka K, Urakawa H, Maruyama N, Kitagawa N etal. Nitric oxide stimulates glucose transport through insulin-independent GLUT4 transloca-tion in 3T3-L1 adipocytes. Eur J Endocrinol 2003; 149: 61 -67.
7. Perdomo G, Martinez-Brocca MA, Bhatt BA, Brown NF, O'Doherty RM, Garcia-Ocana A. Hepatocyte growth factor is a novel stimulator of glucose uptake and metabolism in skeletal muscle cells. J Biol Chem 2008; 283: 13700-13706.
8. Frevert EU, Kahn BB. Differential effects of constitutively active phosphatidylino-sitol 3-kinase on glucose transport, glycogen synthase activity, and DNA synthesis in 3T3-L1 adipocytes. Mol Cell Biol 1997; 17: 190-198.
9. Krishnapuram R, Dhurandhar EJ, Dubuisson O, Kirk-Ballard H, Bajpeyi S, Butte N et al. Template to improve glycemic control without reducing adiposity or dietary fat. Am J Physiol Endocrinol Metab 2011; 300: E779 - E789.
10. Rogers PM, Mashtalir N, Rathod MA, Dubuisson O, Wang ZQ, Dasuri K et al. Metabolically favorable remodeling of human adipose tissue by human adenovirus Ad-36. Diabetes 2008; 57: 2321 -2331.
11. Wang ZQ, Cefalu WT, Zhang XH, Yongmei Y, Qin J, Son L et al. Human adenovirus type 36 enhances glucose uptake in diabetic and non-diabetic human skeletal muscle cells independent of insulin signaling. Diabetes 2008; 57: 1805-1813.
12. Pasarica M, Shin AC, Yu M, Ou Yang HM, Rathod M, Jen KL et al. Human adenovirus 36 induces adiposity, increases insulin sensitivity, and alters hypothalamic monoamines in rats. Obesity (Silver Spring) 2006; 14: 1905-1913.
13. Jiang S, Gavrikova TA, Pereboev A, Messina JL. Adenovirus infection results in alterations of insulin signaling and glucose homeostasis. Am J Physiol Endocrinol Metab 2010; 298: E1295-E1304.
14. Shaw RJ, Cantley LC. Ras, PI(3)K and m TOR signalling controls tumour cell growth. Nature 2006; 441: 424-430.
15. Suire S, Condliffe AM, Ferguson GJ, Ellson CD, Guillou H, Davidson K et al. Gbetagammas and the Ras binding domain of p110gamma are both important regulators of PI(3)Kgamma signalling in neutrophils. Nat Cell Biol2006; 8:1303-1309.
16. Sasaki AT, Chun C,Takeda K, Firtel RA. Localized Ras signaling at the leading edge regulates PI3K, cell polarity, and directional cell movement. J Cell Biol 2004; 167: 505-518.
17. Benito M, Porras A, Nebreda AR, Santos E. Differentiation of 3T3-L1 fibroblasts to adipocytes induced by transfection of ras oncogenes.Science 1991; 253: 565-568.
18. Kozma L, Baltensperger K, Klarlund J, Porras A, Santos E, Czech MP. The ras signaling pathway mimics insulin action on glucose transporter translocation. Proc Natl Acad Sci USA 1993; 90: 4460 - 4464.
19. Dorrestijn J, Ouwens DM, Van den Berghe N, Bos JL, Maassen JA. Expression of a dominant-negative Ras mutant does not affect stimulation ofglucose uptake and glycogen synthesis by insulin. Diabetologia 1996; 39: 558-563.
20. Houseknecht KL, Zhu AX, Gnudi L, Hamann A, Zierath JR, Tozzo E et al. Overexpression of Ha-ras selectively in adipose tissue of transgenic mice. Evidenceforenhanced sensitivity to insulin. J Biol Chem 1996; 271:11347-11355.
21. Ceresa BP, Pessin JE. Insulin regulation of the Ras activation/ inactivation cycle.Mol Cell Biochem 1998; 182: 23-29.
22. Finlay CA, Hinds PW, Levine AJ. The p53 proto-oncogene can act as a suppressor of transformation. Cell 1989; 57: 1083-1093.
23. Rathod M, Rogers PM, Vangipuram SD, Mc Allister EJ, Dhurandhar NV. Adipogenic cascade can be induced without adipogenic media by a human adenovirus. Obesity 2009; 17: 657-664.
24. Brochu M, Malita MF, Messier V, Doucet E, Strychar I, Lavoie JM et al. Resistance training does not contribute to improving the metabolic profile after a 6-month weight loss program in overweight and obese postmenopausal women. J Clin Endocrinol Metab 2009; 94: 3226-3233.
25. Lavoie ME, Rabasa-Lhoret R, Ziai S, Lavoie JC. Blood glutathione peroxidase activity in relation with the risk of cardiovascular diseases. J Diabetes Metab 2011; 2: 2-6.
26. Atkinson RL, Dhurandhar NV, Allison DB, Bowen RL, Israel BA, Albu JB et al. Human adenovirus-36 is associated with increased body weight and paradoxical reduction of serum lipids. Int J Obes (Lond) 2005; 29: 281 -286.
27. Kilroy G, Burk DH, Floyd ZE. High efficiency lipid-based si RNA transfection of adipocytes in suspension. PLo S One 2009; 4: e6940.
28. Jialal I, Devaraj S, Venugopal SK. C-reactive protein: risk marker or mediator in atherothrombosis? Hypertension 2004; 44: 6-11.
29. Visser M, Bouter LM, Mc Quillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999; 282: 2131-2135.
30. Bluher M, Fasshauer M, Tonjes A, Kratzsch J, Schon MR, Paschke R. Association of interleukin-6, C-reactive protein, interleukin-10 and adiponectin plasma concen-trations with measures of obesity, insulin sensitivity and glucose metabolism. Exp Clin Endocrinol Diabetes 2005; 113: 534-537.
31. Foy HM, Grayston JT. Adenoviruses. In: Evans Alfred S (ed). Viral Infections of Humans: Epidemiology and Control. Plenum Medical: New York, 1976, pp 53-70.
32. Horvath J, Palkonyay L, Weber J. Group C adenovirus DNA sequences in human lymphoid cells. J Virol 1986; 59: 189-192.
33. Hierholzer JC, Wigand R, Anderson LJ, Adrian T, Gold JW. Adenoviruses from patients with AIDS: a plethora of serotypes and a description of five new serotypes of subgenus D (types 43-47). J Infect Dis 1988; 158: 804-813.
34. Wigand R, Gelderblom H, Wadell G. New human adenovirus (candidate adenovirus 36), a novel member of subgroup D. Arch Virol 1980; 64: 225-233.
35. Atkinson R, Dhurandhar N, Allison D, Bower R, Israel B. Evidence for an association of an obesity virus with human obesity at three sites in the United States. Int J Obes 1998; 22: S57.
36. Dhurandhar NV, Israel BA, Kolesar JM, Mayhew GF, Cook ME, Atkinson RL. Increased adiposity in animals due to a human virus. Int JObes Relat Metab Disord 2000; 24: 989-996.
37. Dhurandhar NV, Israel BA, Kolesar JM, Mayhew G, Cook ME, Atkinson RL. Transmissibility ofadenovirus-induced adiposity in a chicken model. Int J Obes Relat Metab Disord 2001; 25: 990-996.
38. Dhurandhar NV, Whigham LD, Abbott DH, Schultz-Darken NJ, Israel BA, Bradley SM et al. Human adenovirus Ad-36 promotes weight gain in male rhesus and marmoset monkeys. J Nutr 2002; 132: 3155-3160.
39. Pasarica M, Loiler S, Dhurandhar NV. Acute effect of infection by adipogenic human adenovirus Ad36. Arch Virol 2008; 153: 2097-2102.
40. Dhurandhar NV. A framework for identification of infections that contribute to human obesity. Lancet Infect Dis 2011; 11: 963-969.
41. Bos JL. Ras oncogenes in human cancer: a review. Cancer Res 1989; 49: 4682-4689.
42. Slattery ML, Samowitz W, Curtin K, Ma KN, Hoffman M, Caan B et al. Associations among IRS1, IRS2, IGF1, and IGFBP3 genetic polymorphisms and colorectal cancer. Cancer Epidemiol Biomarkers Prev 2004; 13: 1206-1214.
43. Bader AG, Kang S, Zhao L, Vogt PK. Oncogenic PI3K deregulates transcription and translation. Nat Rev Cancer 2005; 5: 921 -929.
44. Pylayeva Y, Gillen KM, Gerald W, Beggs HE, Reichardt LF, Giancotti FG. Ras- and PI3K-dependent breast tumorigenesis in mice and humans requires focal adhesion kinase signaling.J Clin Invest2009; 119: 252-266.
45. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 57-70.
46. Donehower LA, Harvey M, Slagle BL, Mc Arthur MJ, Montgomery Jr CA, Butel JS et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 1992; 356: 215-221.
47. Ventura A, Kirsch DG, Mc Laughlin ME, Tuveson DA, Grimm J, Lintault L et al. Restoration of p53 function leads to tumour regression in vivo. Nature 2007; 445: 661-665.
48. Boiko AD, Porteous S, Razorenova OV, Krivokrysenko VI, Williams BR, Gudkov AV. A systematic search for downstream mediators of tumor suppressor function of p53 reveals a major role of BTG2 in suppression of Ras-induced transformation. Genes Dev 2006; 20: 236-252.
49. Mistry T, Digby JE, Desai KM, Randeva HS. Leptin and adiponectin interact in the regulation of prostate cancer cell growth via modulation of p53 and bcl-2 expression. BJU Int 2008; 101: 1317-1322.
50. Lipscombe LL, Gomes T, Levesque LE, Hux JE, Juurlink DN, Alter DA. Thiazolidinediones and cardiovascular outcomes in older patients with diabetes. JAMA 2007; 298: 2634-2643.
51. Mc Laughlin T, Lamendola C, Liu A, Abbasi F. Preferential fat deposition in subcutaneous versus visceral depots is associated with insulin sensitivity. J Clin Endocrinol Metab 2011; 96: E1756-E1760.